We are live on ! Find out more
COLL icon

Collegium Pharmaceutical
COLL

178 hedge funds and large institutions have $843M invested in Collegium Pharmaceutical in 2023 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 63 increasing their positions, 70 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

1.19% less ownership

Funds ownership: 114.62% → 113.43% (-1.2%)

10% less capital invested

Capital invested by funds: $936M → $843M (-$92.9M)

10% less repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 70

10% less funds holding

Funds holding: 198 → 178 (-20)

56% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 36

91% less call options, than puts

Call options by funds: $122K | Put options by funds: $1.29M

Holders
178
Holders Change
-20
Holders Change %
-10.1%
% of All Funds
2.79%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
16
Increased
63
Reduced
70
Closed
36
Calls
$122K
Puts
$1.29M
Net Calls
-$1.17M
Net Calls Change
+$1.8M

Top Buyers

1
Victory Capital Management
Victory Capital Management
Texas
+$15.5M
2
Pacer Advisors
Pacer Advisors
Pennsylvania
+$7.65M
3
BlackRock
BlackRock
New York
+$6.05M
4
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$4.68M
5
RCMNY
Rubric Capital Management (New York)
New York
+$3.42M

Top Sellers

1
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
-$6.9M
2
Millennium Management
Millennium Management
New York
-$5.53M
3
CSS
Cubist Systematic Strategies
Connecticut
-$4.7M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$4.59M
5
IECM
Intrinsic Edge Capital Management
Illinois
-$3.88M
Name Holding Trade Value Shares
Change 		Change in
Stake
PTC
176
Private Trust Company
Ohio
$193 – – –
CFGS
177
Concourse Financial Group Securities
Alabama
$171 -$100K -4,419 -100%
MHR
178
Matthew Hamilton Rosenberg
$43 +$45 +2 New
CSS
179
Cubist Systematic Strategies
Connecticut
– -$4.7M -196,096 Closed
IECM
180
Intrinsic Edge Capital Management
Illinois
– -$3.88M -161,610 Closed
NM
181
Newtyn Management
New York
– -$2.4M -100,000 Closed
SGI
182
Summit Global Investments
Utah
– -$2.31M -96,485 Closed
EI
183
EAM Investors
California
– -$1.94M -80,989 Closed
CCIA
184
Campbell & Co Investment Adviser
Maryland
– -$1.63M -68,138 Closed
Calamos Advisors
185
Calamos Advisors
Illinois
– -$1.09M -45,339 Closed
SFI
186
Susquehanna Fundamental Investments
Pennsylvania
– -$780K -32,516 Closed
PMG
187
ProVise Management Group
Florida
– -$729K -30,388 Closed
MA
188
Mutual Advisors
Nebraska
– -$702K -29,252 Closed
DTL
189
Dynamic Technology Lab
Singapore
– -$690K -28,759 Closed
SG Americas Securities
190
SG Americas Securities
New York
– -$587K -24,472 Closed
VCIM
191
Velan Capital Investment Management
Georgia
– -$530K -22,095 Closed
Commonwealth Equity Services
192
Commonwealth Equity Services
Massachusetts
– -$423 -17,652 Closed
AWS
193
Atria Wealth Solutions
New York
– -$403K -16,779 Closed
Baird Financial Group
194
Baird Financial Group
Wisconsin
– -$343K -14,279 Closed
WG
195
Winton Group
United Kingdom
– -$339K -14,145 Closed
N
196
Numerai
California
– -$262K -10,911 Closed
RWM
197
Ritholtz Wealth Management
New York
– -$249K -10,363 Closed
B
198
Bailard
California
– -$230K -9,600 Closed
Robeco Institutional Asset Management
199
Robeco Institutional Asset Management
Netherlands
– -$228K -9,503 Closed
CAN
200
Cetera Advisor Networks
California
– -$201K -8,371 Closed
5 6 7
8
9

COLL Hedge Fund Activity: Q2 2023 in Review

178 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q2 2023, worth a combined $843M — down 9.9% from $936M a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of COLL and 16 opened new positions — a net loss of 20 holders — while 70 trimmed existing stakes and 63 added.

The largest buyer was Victory Capital Management, adding an estimated $15.5M. The largest seller was Cambridge Investment Research Advisors, cutting an estimated $6.9M.

  • 178 institutional investors held Collegium Pharmaceutical (COLL) as of Q2 2023, down from 198 in Q1 2023.
  • Funds reported $843M of Collegium Pharmaceutical stock for Q2 2023, down 9.9% quarter-over-quarter.
  • 16 funds opened new Collegium Pharmaceutical positions in Q2 2023 and 36 closed out, a net change of -20 holders.
  • The largest Collegium Pharmaceutical buyer in Q2 2023 was Victory Capital Management, an estimated $15.5M added.
  • The largest Collegium Pharmaceutical seller in Q2 2023 was Cambridge Investment Research Advisors, an estimated $6.9M sold.

Based on aggregated 13F filings for Q2 2023.